News, infos and good to know WKN: A2QQ2E ISIN: US45256X1037 Forum: Aktien User: Lirumlarum1

ImmunityBio Announces First Dosing of Recombinant BCG (rBCG) in the U.S. and 60 Sites Are in the Process of Launching https://ir.immunitybio.com/news-releases/news-release-details/immunitybio-announces-first-dosing-recombinant-bcg-rbcg-us-and?field_nir_news_date_value[min]=

https://ir.immunitybio.com/news-releases/news-release-details/immunitybio-reports-sales-momentum-unit-growth-permanent-j-code?field_nir_news_date_value[min]=

https://immunitybio.com/immunitybio-receives-fda-rmat-designation-for-anktiva-and-car-nk-for-the-reversal-of-lymphopenia-in-patients-receiving-standard-of-care-chemotherapy-radiotherapy-and-in-treatment-of-multiply-rel/

FDA Authorizes ImmunityBio to Provide Recombinant BCG (rBCG) to Urologists to Address TICE® BCG Shortage https://ir.immunitybio.com/news-releases/news-release-details/fda-authorizes-immunitybio-provide-recombinant-bcg-rbcg?field_nir_news_date_value[min]=

https://www.stocktitan.net/news/IBRX/immunity-bio-announces-uk-medicines-and-healthcare-products-9bjg4294w22a.html

ImmunityBio Announces UK Medicines and Healthcare Products Regulatory Agency Accepted Marketing Authorization Application for ANKTIVA® for the Treatment of Patients with BCG-unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In Situ https://ir.immunitybio.com/news-releases/news-release-details/immunitybio-announces-uk-medicines-and-healthcare-products?field_nir_news_date_value[min]=